Healthcare Equipment and Supplies
Company Overview of Therasis, Inc.
Therasis, Inc. is a drug discovery company that develops oncology therapeutics for use as single agents and in combination therapy. It offers Therasis Filter, which enables the identification of disease-specific alterations in networks of molecular interactions that regulate cellular processes. The company was incorporated in 2007 and is based in New York, New York.
462 First Avenue
New York, NY 10016
Founded in 2007
Key Executives for Therasis, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Therasis, Inc., please visit www.therasis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.